UNIVERSITY OF IOWA HUNTINGTON'S DISEASE CENTER FOR EXCELLENCE

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 爱荷华大学被美国亨廷顿病学会(HDSA)指定为亨廷顿病卓越中心。HDSA家庭服务和研究卓越中心是HDSA公认的具有亨廷顿病专业知识的医疗机构。HDSA中心提供了一种多学科的方法来治疗这种复杂的、无情的进行性疾病。服务包括但不限于神经学、精神病学、言语、物理和职业治疗、遗传咨询和基因检测以及社会工作和区域转介。HDSA的卓越中心项目取得了无与伦比的成功。亨廷顿病卓越中心是加强临床研究的最新模式，成立的目的是以协调的方式进行基础和临床研究。中心活动的集中位置对于实现这种协调至关重要。将医疗服务与研究机会相结合是治疗这种复杂疾病的有效方法，目前尚无有效的治疗方法。随着该中心的发展，预计临床试验的数量将随之而来，加强努力寻找减缓疾病进展的方法，并最终找到治愈方法。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The University of Iowa has been designated a Huntington's Disease (HD) Center for Excellence by the Huntington's Disease Society of America (HDSA). HDSA Centers of Excellence for Family Services and Research are medical facilities that have been recognized by HDSA as having expertise in Huntington's disease. HDSA Centers provide a multidisciplinary approach to the treatment of this complex, relentlessly progressive disease. Services include, but are not limited to, neurology, psychiatry, speech, physical and occupational therapys, genetic counseling and genetic testing as well as social work and regional referrals. The success of HDSA's Centers of Excellence program has been unparalleled. The Huntington's Disease Center of Excellence is the newest model for enhancing clinical research, formed to conduct basic and clinical research in a coordinated manner. A centralized location for Center activities is critical in making this coordination possible. Combining medical services with research opportunities serves as an efficient approach to this complex disease, for which no effective treatment currently exists. As the Centers develop it is expected that an increase in the number of clinical trials will follow, enhancing efforts at finding ways to slow down disease progression, and ultimately finding a cure.